Biogen Inc

NASDAQ:BIIB   3:59:57 PM EDT
327.10
-2.07 (-0.63%)
Products

FDA Calls For Federal Investigation Into Controversial Alzheimer's Drug Approval To Biogen- Stat

Published: 07/09/2021 17:05 GMT
Biogen Inc (BIIB) - U.S. FDA Calls for Federal Investigation Into Its Controversial Alzheimer's Drug Approval - Stat News.
Head of FDA Has Called for Wide-ranging Federal Investigation Into Approval of Biogen's Treatment for Alzheimer's Disease- Stat News.
Further Company Coverage: Biibo ((reuters.
Briefs@thomsonreuters.
Com;)).